| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.49 | 0.0003 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |